| GALAXA LEONOVUS INC.
1907017 29 Jun 2018 | on 29 Jul 2021 | Class 042 Class 042 Computer & Software Services & Scientific Services Cloud computing provider services for general storage of data; Creating and maintaining a secure blockchain-enabled global marketplace for cloud storage and compute resources with associated blockchain payment system, on which any developer can build enterprise applications | | | GATTEXA TAKEDA PHARMACEUTICALS U.S.A. INC.
1792917 25 Jul 2016 | on 17 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, namely, hypocalcemia, endocrine disorders, namely, hypoparathyroidism, and bone metabolism disorders. | | | GATEXA SHIRE-NPS PHARMACEUTICALS INC.
1564734 17 Feb 2012 | on 14 Mar 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, namely, depression, schizophrenia, bipolar disorder, strokes and spasticity, endocrine disorders, namely, parathyroid disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management. | | | GATTEXA SHIRE-NPS PHARMACEUTICALS INC.
1218876 25 May 2004 | on 14 Sep 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders. | | | GATEXA NPS PHARMACEUTICALS INC.
(A DELAWARE CORPORATION)
1218874 25 May 2004 | on 14 Mar 2012 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases namely, bacterial and fungal infections, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, namely, depression, schizophrenia, bipolar disorder, strokes and spasticity, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management. | |